'%3e%3cpath%20id='s'%20d='M0,162.5%2022.041947,230.338137%20-35.664619,188.411863H35.664619L-22.041947,230.338137z'/%3e%3cuse%20xlink:href='%23s'%20y='-400'/%3e%3cg%20id='s5'%3e%3cuse%20xlink:href='%23s'%20transform='rotate(30)%20rotate(-30,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(60)%20rotate(-60,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(90)%20rotate(-90,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(120)%20rotate(-120,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(150)%20rotate(-150,0,200)'/%3e%3c/g%3e%3cuse%20xlink:href='%23s5'%20transform='scale(-1,1)'/%3e%3c/g%3e%3c/svg%3e)
Horizon Europe
[Horizon - Health] Innovative antimicrobials against pathogens resistant to antimicrobials (AMR)
Expected to open. Consortium; UK + US entities fundable; SMEs as partners
Award
EUR 8-10m
Collaborative
Next deadline
Closes: 16 April 2027 (expected)
Strong applications take weeks to build. Start now.
What it funds
Expected to open. Consortium; UK + US entities fundable; SMEs as partners
Who it suits
Consortium; UK + US entities fundable; SMEs as partners
- Life sciences & health
- Industrial R&D
Programme specifications
Award bandEUR 8-10m
FunderHorizon Europe
RegionUK-wide
Partners requiredYes
Next deadline16 April 2027
Key sectors
Life sciences & health
Considering [Horizon - Health] Innovative antimicrobials against pathogens resistant to antimicrobials (AMR)?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.